J Cerebrovasc Endovasc Neurosurg > Volume 27(3); 2025 > Article
Phyo, Shirakawa, Matsukawa, Uchida, Kuwahara, Senda, Miyazaki, and Yoshimura: The efficacy and safety of stent-assisted coil embolization with the semi-jailing technique in patients with unruptured intracranial aneurysm

Abstract

Objective

The stent-assisted coiling (SAC) is a well-known procedure for wide neck intracranial aneurysms. To date, the impact of the semi-jailing technique (SJT) on outcomes in patients with SAC remains unknown. This study aims to evaluate the efficacy and safety of SAC using open- or closed-cell stents in patients with unruptured intracranial aneurysms.

Methods

The data of patients treated with SAC between December 2013 and May 2022 was retrospectively investigated. Clinical, aneurysmal, outcomes were compared between patients with and without SJT. The primary outcome was 1-year complete occlusion defined as the Raymond-Roy occlusion classification class I. Safety outcomes included permanent deficits and mortality. Subgroup analysis was also performed regarding open-cell or closed-cell stents.

Results

Among 320 patients with SAC, 220 patients undertook SJT (68.8%). The median age of patients was 61.0 years (interquartile range, 50.3-71.0 years) and 73 were male (22.8%). 1-year complete occlusion was obtained in 221 patients (69.1%). Permanent deficits and mortality were observed in 3 (0.9%) and 1 (0.3%) patient, respectively. Compared to non-SJT, SJT was significantly related to 1-year complete occlusion (73.2% vs. 60.0%, adjusted odds ratio 1.85, 95% confidence interval 1.11-3.09, p=0.02). Safety outcomes showed no significant difference between SJT and non-SJT.

Conclusions

The results of this study showed the efficacy and safety of SJT in unruptured intracranial aneurysm patients treated with SAC.

INTRODUCTION

Cerebral aneurysms (ANs) are a potentially life-threatening condition that requires prompt and effective treatment. Consequently, the increased frequency of neuroimaging during health check-up for minor symptoms has led to a steady rise in the incidence of unruptured intracranial aneurysms (IAs) [24]. Over the years, various methods have been used to treat the cerebral AN, and endovascular therapy has become popular and has been developed to treat wide neck ruptured and unruptured IAs [13,14].
To avoid coil protrusion into the parent vessel and insufficient occlusion of the aneurysm, various endovascular techniques have been developed. Previously balloon-assisted coil embolization (BAC) was one of the treatment options to treat wide neck aneurysms. BAC intermittently occluded the parent artery, potentially resulting in unanticipated flow disruption to regional area of the brain. In addition, unexpected overinflation and vessel rupture can lead to catastrophic events.
Stent-assisted coil embolization (SAC) is the widely acceptable technique for treating wide neck IAs [8]. SAC is a minimally invasive procedure that uses a stent to support the coils to occlude the AN. The goal of this procedure is to prevent the AN from rupturing and potentially causing stroke without procedural complications. A variety of factors influence the success of SAC, including the size and location of the AN, the features of the patient’s blood vessels, and the experience and ability of the medical team executing the procedure. Several reports have highlighted the effectiveness of SAC over other techniques in addressing these risks. Over time, several studies reported that the AN with a wider neck was more likely to use SAC technique [1,23].
Among SAC, there have been various techniques including dual-stent techniques (Y- and X-stenting), trans-circulation stenting, and antegrade horizontal stenting [3,15,25]. In addition to these techniques, Hong et al. first introduced the semi-jailing technique (SJT), in which the stent was partially deployed across the aneurysm neck to secure the coils in place while also enabling blood flow to be maintained [6]. They concluded that SJT was a safe and effective SAC technique that facilitates the treatment of complex, wide-necked aneurysms. The SJT was typically performed with a resheathable closed-cell stent but may encounter issues with tortuous blood vessels including stent migration and malapposition [4,5,6]. On the other hand, our previous study indicated that although the open-cell stent carries the disadvantage of an unresheathable design, coil placement with a shorter stent deployment length may be advantageous during SJT for internal carotid artery aneurysm embolization with favourable consequences for excellent vessel wall apposition [18].
To date, the definite impact of the SJT on outcomes in patients with unruptured IAs remains unknown. We aimed to evaluate the efficacy and safety of SJT using open- or closed-cell stents in the treatment of patients with unruptured IA.

MATERIAL AND METHODS

This study was based on the Strengthening the Reporting of Observational Study in Epidemiology statement [22]. A single-center, hospital-based observational study was conducted with a retrospective approach. The study protocol was approved by the institutional ethics committee at Hyogo Medical University (No. 4552), and the need for informed consent was waived. Patients with unruptured IAs who were treated with SAC in our hospital between December 2013 and May 2022 were retrospectively evaluated.
Patient characteristics (age, sex, past medical history, and previous treatment of IA) were obtained through a review of the patient’s medical records. Aneurysm characteristics (side, size, shape, morphology, whether IA was growing or not, side-wall type, branch from the aneurysm sac, aneurysm shape, and previous treatment for the same aneurysm) were also obtained.
SAC was performed using open and closed cell stents (Neuroform and Neuroform Atlas: Stryker, Freemont, San Francisco, California, USA, Enterprise: Cordis Neurovascular, Miami, FL, USA, LVIS: MicroVention, Tustin, CA, USA). Details of SAC and SJT were described in the previously published study [12]. The non-SJT group consisted of jailing and trans-cell techniques.

Endovascular treatment for semi-jailing technique

Antiplatelet regimen before the procedure, antiplatelets were started 14 days before the surgery, aspirin 100 mg/day, and clopidogrel 75 mg/day. Platelet aggregation pattern was checked before the procedure usually on 10th day of antiplatelet treatment and adjusted according to the result of it. After confirming, the good platelet inhabitation by the verify now, we started the procedure 5-7.
7-French guiding catheter, Shuttle Guiding Sheath (Cook, USA) was advanced for ant circulation and 6 F guiding catheter for post circulation was used via the femoral artery and navigated to the internal carotid artery (ICA). After administering 5,000 units of intravenous heparin, (unfractionated heparin: UFH), a stent-delivery microcatheter was placed the target vessel to deliver the stent. A coil-delivery microcatheter was positioned within the aneurysm to insert the coils. For the semi-jailing technique, the stent was partially deployed to cover 3/4 of the aneurysmal sac to prevent the coil loop protrusion into the parent artery. Coil embolization was started deploying three-quarters of stent. Following successful embolization, the remaining stent was fully deployed to cover the aneurysmal sac.
During the procedure, heparin was injected according to activated clotting time (ACT), maintaining standard was between 250 to 300 seconds. Postoperatively, dual antiplatelet therapy was continued for 3 months, followed by single-agent therapy until withdrawal at 1 year.

Patient selection

Among 1,600 cases with IAs who underwent SAC in our hospital, 502 had surgical intervention and 15 received hybrid procedures were excluded. Additionally, from the remaining 1,085 cases who had endovascular therapy (EVT), 685 cases without SAC, 7 cases with ruptured aneurysms, 9 recuse stents cases (defined as unintended stent placement), 12 cases with multiple stents, and 52 cases with unsatisfied data were also excluded. Finally, 320 patients who underwent SAC for unruptured intracranial aneurysms were enrolled (Fig. 1).

Measuring the outcome

The primary outcome was 1-year complete occlusion of IA defined as Raymond-Roy classification class I [16]. Raymond-Roy classification was reviewed by two independent clinicians (S.K and M.S) as part of the clinical routine on magnetic resonance angiography or conventional digital subtraction angiography. Secondary outcomes included 1-year satisfactory aneurysm occlusion defined as Raymond-Roy classification class I and II, good outcome defined as a modified Rankin Scale score (mRS) of 0 to 2, and retreatment of treated IA [21]. Safety outcomes consisted of perioperative complications, symptomatic complications, mortality, and post-treatment IA rupture. Symptomatic complications were defined as an increase of mRS >2.

Statistical analysis

Categorical variables were expressed as percentages and analysed using the χ2 test while continuous variables were expressed as median and using non-parametric Wilcoxon analysis test. Pearson’s chi-square test was also used to assess associations between categorical variables, complemented by adjusted residual analysis. Variables and outcomes were compared between patients with and without SJT. Clinical and technical characteristics and outcomes were compared between SJT and non-SJT groups. In addition, they were also compared by type of the stents.
Adjustment factors were age>70 years, aneurysm dome-to-neck ratio<1.5, side wall aneurysm, and branching from the aneurysm [2,8,11,12,17,18,20]. The reason for dichotomizing the continuous variables was based on previous reports. The subgroups for primary outcomes were estimated by the multivariate logistic regression models with the same adjuster. All statistical analyses were performed using JMP Pro (version 15.2.0; SAS Institute Inc., Cary, North Carolina, USA). p<0.05 was considered statistically significant.

RESULTS

A total of 320 patients were included and 220 patients undertook SJT (68.8%) (Fig. 1). Demographic and aneurysm characteristics are shown in Table 1. The median age of patients was 61.0 years (interquartile range, 50.3-71.0 years) and 73 were male (22.8%). Patients with SJT were significantly younger (59.0 vs. 66.0 years, p=0.01) and less likely to have hypertension (35.9% vs. 57.0%, p<0.01). Other demographic characteristics showed no significant difference between the two groups. Right side IA location was more frequently observed in patients with SJT (46.8% vs. 36.0%, p<0.05 by residual analysis). Maximum diameter and neck size were significantly smaller in patients with SJT (5.3 vs. 7.2 mm, p<0.01; 4.2 vs. 5.3 mm, p<0.01, respectively). Proportion of sidewall IA was significantly smaller in patients with SJT (57.3% vs. 69.0%, p=0.046). Patients with SJT were more likely to have internal carotid artery aneurysms and less likely to have basilar artery aneurysms (46.4% vs. 33.0%, p<0.05; 5.0% vs. 20.0%, p<0.05 by residual analysis, respectively). Other aneurysm characteristics showed no significant differences between the two groups.

Outcome

Compared to non-SJT, SJT was significantly related to 1-year complete occlusion (73.2% vs. 60.0%, crude odds ratio [OR] 1.82,95% confidence interval [CI] 1.10-3.00; adjusted OR 1.85, 95% CI 1.11-3.09, p=0.02) (Table 2). SJT was also significantly related to 1-year satisfactory occlusion (83.6% vs. 71.0%, crude OR 2.09, 95% CI 1.19-3.66; adjusted OR 2.11, 95% CI 1.19-3.75, p=0.01). Other secondary outcomes and safety outcomes showed no significant difference between two groups.

Subgroup analysis

Patients with SJT had consistently higher ORs with the upper boundaries of 95% CI above 1 except for patients with age <70 years, closed cell stent, dome-to-neck ratio (DTN) <1.5, branch from IA dome (yes and no), and bifurcation type IA (Fig. 2). SJT patients with DTN ≥1.5 (adjusted OR 10.3, 95% CI 2.26-46.6, interaction p=0.02) had a significantly high proportion of 1-year complete occlusion.

DISCUSSION

Our study aimed to evaluate the clinical outcomes and efficacy of the SJT and non-SJT. The results of this study showed that obliteration rate of SJT was significantly higher than non-SJT and was related to 1-year complete and satisfactory occlusions in unruptured IA patients treated with SAC. Hong et al. introduced SJT and have described good result in occlusion rate [6]. This finding is consistent with earlier research that has shown efficacy of SJT approaches and align with the results of our study [9,18]. Subgroup analysis demonstrated that SJT for side-wall type IA was more related to 1-year complete occlusion.
The jailing technique restricts the movement of the coil delivery microcatheter, resulting in difficulties achieving paint-brushing or back-and-forth movement of the microcatheter [19]. In the trans-cell technique, although the microcatheter can move freely, it can easily be forced out of the aneurysm during coiling. In addition, the transcell technique is difficult because the microcatheter might become stuck in the struts of the open cell stent [7]. Besides, the transcell technique may be dangerous because the microcatheter can suddenly jump into the aneurysm sac, perforating the aneurysm [7]. Therefore, the jailing and transcell techniques could be evaluated as options on a case-by-case basis.
As stated above, repositioning of the microcatheter, enabling a compartmental approach, is often critical to safely achieving high coil packing densities in aneurysm necks, irregularly shaped multilobed aneurysms, and recurrent aneurysms. In this regard, Hong et al. introduced SJT, which could provide stent-assisted remodelling of the aneurysm neck during coil embolization without pinning the coil delivery microcatheter and has described good result in occlusion rate. The results of our previous and current study supported their results [6,18]. Additionally, the SJT can assist in maintaining blood flow to adjacent brain tissue, which can be essential in lowering the risk of stroke. It has good durability when manipulating the microcatheter and it can adjust the microcatheter during embolization. Furthermore, when deployed in difficult parent arteries, the open cell stent can provide adequate anchoring to the parent artery and reduce the chance of stent migration during microcatheter withdrawal. It can also improve inadequate expansion and apposition. This creates a sturdy framework for the coils to stick to and lowers the possibility of their becoming squeezed or dislodged over time. Closed cell stent has good efficacy with using the semi-jailing technique. However, the effectiveness of proper anchoring to the tortuous parent artery seemed to be less than using the open cell stent. Therefore, choosing the appropriate stent is one of the important factors which influencing clinical outcomes. There have been several reports regarding the effectiveness of the SJT, nevertheless, they didn’t compare the treatment results between two methods, SJT and non-SJT on using open-cell and closed-cell stents [9-11]. To our knowledge, this is the first report comparing the efficacy and safety of the open-cell and closed-cell stents in SAC.
Although no statistically significant differences were identified in perioperative complications of SJT and non-SJT, 1-year complete and satisfactory occlusion were significantly higher in SJT group. Shirakawa et al. described the effectiveness of SJT on open-cell stents, by comparing the outcomes of open and closed-cell stents where in SJT was applied. In which, the rate of immediate occlusion after the procedure tended to be higher in SJT with open cell stent group [18]. This may be because the open-cell stent gave good anchoring to the parent artery, and SJT allowed the microcatheter to get more free space while manipulating inside the aneurysm with proper expansion of the stent. In addition, SJT with dome-to-neck ratio ≥1.5 and with side-wall location were significantly and marginally related to higher 1-year complete occlusion in the subgroup analysis. Therefore, SJT may be a good option for treating IAs with these morphological characteristics. Furthermore, periprocedural hemorrhagic complications in non-SJT tended to increase (1.8% vs. 5.0%, p = 0.14) although the difference was not significant. This might be due to the limited mobility of the microcatheter and difficulty to reinsert the microcatheter into the aneurysm after being forced out of the aneurysm during embolization in the non-SJT [7]. On the contrary, SJT could offer more free space in manipulating the microcatheter during the coil embolization, therefore, the exceeded frictional force between the microcatheter and the wall of the vessel due to narrow space might be avoided. As a result, SJT ensures the proper manipulation of the microcatheter during embolization, leading to successful coil packing within the AN. Furthermore, it allows for adjustments to the stent during both embolization and deployment, particularly in challenging vessels, resulting in favourable obliteration of long-term technical outcomes.

Limitation

First, since the data for this study came from a single centre and the analysis was done retrospectively, the generalizability of the results of the present study is limited. Second, the occurrence rate of anterior circulatory aneurysms was higher in our study because most of the posterior circulation aneurysms were eligible for treatment with flow-diverting devices in our institute; therefore, this could lead to a selection bias. Third, there were no clear indications for choosing SJT over non-SJT, which may introduce minor selection bias. However, baseline characteristic was similar between groups. Fourth, as the follow-up duration was only one-year, long-term impact of SJT on outcomes could not be identified.

CONCLUSIONS

SJT provided the noticeable good technical outcomes in achieving 1-year complete and satisfactory occlusions. In subgroup analysis for 1-year complete occlusion, SJT with sidewall type IA was more related to good outcomes. The satisfactory durability of SJT makes it a better choice as a technique in SAC in terms of technical effectiveness in clinical setting, especially in challenging vessels. Further prospective multicenter studies with larger sample sizes are necessary to improve the routine treatment regimens and outcomes.

NOTES

Disclosure

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Fig. 1.
Study flow chart Non-SJT (n=100)
*Simple coil embolization first, followed by stent deployment as rescue. EVT indicates endovascular treatment; SAC, stent-assisted coiling; SJT, semi-jailing technique.
jcen-2025-e2025-01-003f1.jpg
Fig. 2.
Subgroup analysis for primary outcome
AN, indicates aneurysm; CI, confidence interval; CO, complete occlusion; DNR, dome-to-neck ratio; OR, odds ratio; SJT, semi-jailing technique.
jcen-2025-e2025-01-003f2.jpg
Table 1.
Demographic and aneurysm characteristics in patients with and without semi-jail technique
Variables Total
SJT
Non-SJT
p value
n=320 n=220 n=100
Demographic variables
Age, y, median (IQR) 61.0 (50.3-71.0) 59.0 (50.0-70.8) 66.0 (53.0-73.0) 0.01
Male 73 (22.8) 51 (23.2) 22 (22.0) 0.82
Past medical history
 Hypertension 136 (42.5) 79 (35.9) 57 (57.0) <0.01
 Diabetes mellitus 15 (4.7) 7 (3.2) 8 (8.0) 0.08
 Dyslipidemia 93 (29.1) 60 (27.3) 33 (33.0) 0.29
 Chronic heart failure 4 (1.3) 3 (1.4) 1 (1.0) 1.00
Previous treatment of aneurysm 44 (13.8) 29 (13.2) 15 (15.0) 0.66
Aneurysm characteristics
Aneurysm side 0.04
 Right 139 (43.4) 103 (46.8) 36 (36.0)
 Left 140 (43.8) 95 (43.2) 45 (45.0)
 Medial 41 (12.8) 22 (10.0) 19 (19.0)
Size
 Max diameter, median (IQR) 5.7 (4.4-7.7) 5.3 (4.2-7.0) 7.2 (5.2-10.5) <0.01
 Neck size, median (IQR) 4.4 (3.5-5.9) 4.2 (3.3-5.3) 5.3 (4.2-7.0) <0.01
  >4 mm 200 (62.5) 124 (56.4) 76 (76.0) <0.01
 Dome to neck ratio, median (IQR) 1.2 (1.0-1.4) 1.2 (1.1-1.4) 1.2 (1.0-1.4) 0.73
  <1.5 262 (81.9) 180 (81.8) 82 (82.0) 0.97
Saccular shape 291 (90.9) 201 (91.4) 90 (90.0) 0.69
Morphology of the aneurysms 0.66
 Multilobe 24 (7.5) 15 (6.8) 9 (9.0)
 Bleb 100 (31.3) 67 (30.5) 33 (33.0)
 Smooth 196 (61.3) 138 (62.7) 58 (58.0)
Growing aneurysm 78 (24.4) 54 (24.6) 24 (24.0) 0.92
Side-wall aneurysm 195 (60.9) 126 (57.3) 69 (69.0) 0.04
Branching from aneurysm 154 (48.1) 104 (47.3) 50 (50.0) 0.65
Location of the aneurysms <0.01
 Anterior communicating artery 20 (6.3) 15 (6.8) 5 (5.0)
 Middle cerebral artery 20 (6.3) 13 (5.9) 7 (7.0)
 Anterior choroidal artery 15 (4.7) 11 (5.0) 4 (4.0)
 Ophthalmic artery 23 (7.2) 17 (7.7) 6 (6.0)
 Anterior cerebral artery 2 (0.6) 2 (0.9) 0
 Internal carotid artery 135 (42.2) 102 (46.4) 33 (33.0)
 Posterior communicating artery 43 (13.4) 29 (13.2) 14 (14.0)
 Posterior cerebral artery 2 (0.6) 2 (0.9) 0
 Basilar artery 31 (9.7) 11 (5.0) 20 (20.0)
 Vertebral artery 29 (9.1) 18 (8.2) 11 (11.0)
Open cell stent 202 (63.1) 141 (64.1) 61 (61.0) 0.59

CI, confidence interval; IQR, interquartile range

Table 2.
Technical and clinical outcomes of the patients with and without semi jailing technique
Outcome Total
SJT
Non-SJT
Crude
Adjusted*
n=320 n=220 n=100 OR (95% CI) p value OR (95% CI) p value
Primary
1-year complete occlusion 221 (69.1) 161 (73.2) 60 (60.0) 1.82 (1.10-3.00) 0.01 1.85 (1.11-3.09) 0.02
Secondary
1-year satisfactory occlusion 255 (79.7) 184 (83.6) 71 (71.0) 2.09 (1.19-3.66) <0.01 2.11 (1.19-3.75) 0.01
1-year good outcome 314 (98.1) 215 (97.7) 99 (99.0) 0.43 (0.05-3.77) 0.67 0.38 (0.04-3.42) 0.39
Retreatment, n (%) 16 (5.1) 11 (5.0) 5 (5.1) 0.98 (0.33-2.91) 1.00 0.84 (0.27-2.58) 0.76
Perioperative complications
In-stent thrombosis or stenosis 3 (0.9) 2 (0.9) 1 (1.0) 0.91 (0.08-10.1) 1.00 1.07 (0.08-13.3) 0.96
Coil loop protrusion into the parent artery 16 (5.0) 11 (5.0) 5 (5.0) 1.00 (0.34-2.96) 1.00 0.88 (0.29-2.68) 0.82
Peri-procedural intracranial hemorrhagic complication 9 (2.8) 4 (1.8) 5 (5.0) 0.35 (0.09-1.34) 0.14 0.37 (0.09-1.42) 0.15
Symptomatic complications with mRS >2 2 (0.6) 1 (0.5) 1 (1.0) 0.45 (0.03-7.30) 0.53 0.55 (0.03-9.19) 0.68
Mortality 1 (0.3) 1 (0.5) 0 - NA - NA
Post-treatment rupture 2 (0.6) 1 (0.5) 1 (1.0) 0.45 (0.03-7.30) 0.53 0.26 (0.01-4.62) 0.36

Data expressed as number of patients (%), unless otherwise indicated.

* Adjusted factors: age (≥70 or <70), stent type (open or closed cell), dome-to-neck ratio (≥1.5 or <1.5), branch from aneurysm dome (yes or no), side wall or bifurcation type.

CI, confidence interval; IQR, interquartile range; mRS, modified Rankin Scale; NA, not applicable; OR, odds ratio; SJT, semi-jail technique.

REFERENCES

1. Akpek S, Arat A, Morsi H, Klucznick RP, Strother CM, Mawad ME. Self-expandable stent-assisted coiling of wide-necked intracranial aneurysms: A single-center experience. AJNR Am J Neuroradiol. 2005 May;26(5):1223-31.
pmid pmc
2. Chalouhi N, Jabbour P, Singhal S, Drueding R, Starke RM, Dalyai RT, et al. Stent-assisted coiling of intracranial aneurysms: Predictors of complications, recanalization, and outcome in 508 cases. Stroke. 2013 May;44(5):1348-53.
crossref pmid
3. Ciccio G, Robert T, Smajda S, Fahed R, Desilles JP, Redjem H, et al. Double stent assisted coiling of intracranial bifurcation aneurysms in Y and X configurations with the Neuroform ATLAS stent: Immediate and mid-term angiographic and clinical follow-up. J Neurointerv Surg. 2019 Dec;11(12):1239-42.
crossref pmid
4. Heller RS, Malek AM. Delivery technique plays an important role in determining vessel wall apposition of the Enterprise self-expanding intracranial stent. J Neurointerv Surg. 2011 Dec;3(4):340-3.
crossref pmid pmc
5. Heller RS, Malek AM. Parent vessel size and curvature strongly influence risk of incomplete stent apposition in enterprise intracranial aneurysm stent coiling. AJNR Am J Neuroradiol. 2011 Oct;32(9):1714-20.
crossref pmid pmc
6. Hong B, Patel NV, Gounis MJ, DeLeo MJ 3rd, Linfante I, Wojak JC, et al. Semi-jailing technique for coil embolization of complex, wide-necked intracranial aneurysms. Neurosurgery. 2009 Dec;65(6):1131-8; discussion 1138-9.
crossref pmid pdf
7. Hou K, Yu J. Application of the neuroform atlas stent in intracranial aneurysms: Current status. Front Neurol. 2022 Mar;13:829143.
crossref pmid pmc
8. King B, Vaziri S, Singla A, Fargen KM, Mocco J. Clinical and angiographic outcomes after stent-assisted coiling of cerebral aneurysms with Enterprise and Neuroform stents: A comparative analysis of the literature. J Neurointerv Surg. 2015 Dec;7(12):905-9.
crossref pmid
9. Ko JK, Cho WH, Cha SH, Choi CH, Lee SW, Lee TH. Semi-jailing technique using a neuroform3 stent for coiling of wide-necked intracranial aneurysms. J Korean Neurosurg Soc. 2017 Mar;60(2):146-54.
crossref pmid pmc pdf
10. Kwon O, Chung J. OOutcomes of stent-assisted coiling using the neuroform atlas stent in unruptured wide-necked intracranial aneurysms. J Korean Neurosurg Soc. 2021 Jan;64(1):23-9.
crossref pmid pdf
11. Lefevre PH, Schramm P, Kemmling A, Barreau X, Marnat G, Piotin M, et al. Multi-centric European post-market follow-up study of the Neuroform Atlas Stent System: Primary results. J Neurointerv Surg. 2022 Jul;14(7):694-8.
crossref pmid
12. Liang G, Gao X, Li Z, Wei X, Xue H. Neuroform stent-assisted coiling of intracranial aneurysms: A 5-year single-center experience and follow-up. Neurol Res. 2010 Sep;32(7):721-7.
crossref pmid
13. Lin N, Cahill KS, Frerichs KU, Friedlander RM, Claus EB. Treatment of ruptured and unruptured cerebral aneurysms in the USA: a paradigm shift. J Neurointerv Surg. 2018 Jul;10(Suppl 1):i69-i76.
crossref pmid
14. Luther E, McCarthy DJ, Brunet MC, Sur S, Chen SH, Sheinberg D, et al. Treatment and diagnosis of cerebral aneurysms in the post-international subarachnoid aneurysm trial (ISAT) era: Trends and outcomes. J Neurointerv Surg. 2020 Jul;12(7):682-7.
crossref pmid
15. Mascitelli JR, Levitt MR, Griessenauer CJ, Kim LJ, Gross B, Abla A, et al. Transcirculation approach for stent-assisted coiling of intracranial aneurysms: A multicenter study. J Neurointerv Surg. 2021 Aug;13(8):711-5.
crossref pmid
16. Mascitelli JR, Moyle H, Oermann EK, Polykarpou MF, Patel AA, Doshi AH, et al. An update to the Raymond-Roy occlusion classification of intracranial aneurysms treated with coil embolization. J Neurointerv Surg. 2015 Jul;7(7):496-502.
crossref pmid
17. Piotin M, Blanc R, Spelle L, Mounayer C, Piantino R, Schmidt PJ, et al. Stent-assisted coiling of intracranial aneurysms: Clinical and angiographic results in 216 consecutive aneurysms. Stroke. 2010 Jan;41(1):110-5.
crossref pmid
18. Shirakawa M, Yoshimura S, Uchida K, Yamada K, Sakamoto D, Iida T, et al. Coil embolization for cerebral aneurysms using a semi-jailing technique and open-cell stent. World Neurosurg. 2019 May;125:e16-e21.
crossref pmid
19. Spiotta AM, Wheeler AM, Smithason S, Hui F, Moskowitz S. Comparison of techniques for stent assisted coil embolization of aneurysms. J Neurointerv Surg. 2012 Sep;4(5):339-44.
crossref pmid
20. Ulfert C, Pham M, Sonnberger M, Amaya F, Trenkler J, Bendszus M, et al. The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: A multicentre experience. J Neurointerv Surg. 2018 Dec;10(12):1192-6.
crossref pmid
21. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988 May;19(5):604-7.
crossref pmid
22. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007 Oct;370(9596):1453-7.
crossref pmid
23. Wang J, Vargas J, Spiotta A, Chaudry I, Turner RD, Lena J, et al. Stent-assisted coiling of cerebral aneurysms: A single-center clinical and angiographic analysis. J Neurointerv Surg. 2018 Jul;10(7):687-92.
crossref pmid
24. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain. 2000 Feb;123(Pt 2):205-21.
crossref pmid
25. Yashar P, Kan PT, Levy EI. Horizontal deployment of an intracranial stent via an antegrade approach for coil embolization of a basilar apex aneurysm: Technical note. J Neurointerv Surg. 2011 Dec;3(4):355-7.
pmid


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
The Journal of Cerebrovascular and Endovascular Neurosurgery (JCEN), Department of Neurosurgery, Wonkwang University
School of Medicine and Hospital, 895, Muwang-ro, Iksan-si, Jeollabuk-do 54538, Korea
Tel: +82-2-2279-9560    Fax: +82-2-2279-9561    E-mail: editor.jcen@the-jcen.org                

Copyright © 2026 by Korean Society of Cerebrovascular Surgeons and Korean NeuroEndovascular Society.

Developed in M2PI

Close layer
prev next